Daniel Lavanchy

Summary

Affiliation: World Health Organization
Country: Switzerland

Publications

  1. doi request reprint The global burden of hepatitis C
    Daniel Lavanchy
    World Health Organization, Geneve, Switzerland
    Liver Int 29:74-81. 2009
  2. ncbi request reprint Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention
    D Lavanchy
    World Health Organization, Department of Communicable Diseases Surveillance and Response, Geneva, Switzerland
    J Clin Virol 34:S1-3. 2005
  3. ncbi request reprint Hepatitis C: public health strategies
    D Lavanchy
    World Health Organization WHO, Communicable Diseases Surveillance and Response, Geneva, Switzerland
    J Hepatol 31:146-51. 1999
  4. ncbi request reprint Hepatitis C
    D Lavanchy
    World Health Organization, Communicable Diseases Surveillance and Response, Geneva, Switzerland
    Can J Gastroenterol 14:67B-76B. 2000
  5. ncbi request reprint Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures
    D Lavanchy
    World Health Organization, Communicable Disease Surveillance and Response, Geneva, Switzerland
    J Viral Hepat 11:97-107. 2004
  6. doi request reprint Chronic viral hepatitis as a public health issue in the world
    Daniel Lavanchy
    World Health Organization WHO, HSE EPR BDP, Geneve, Switzerland
    Best Pract Res Clin Gastroenterol 22:991-1008. 2008
  7. doi request reprint Treatment of chronic hepatitis B virus infection in resource-constrained settings: expert panel consensus
    Steven T Wiersma
    World Health Organization, FCH IVB, Geneva, Switzerland
    Liver Int 31:755-61. 2011
  8. ncbi request reprint Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants
    David FitzSimons
    World Health Organization, Via Appia 20, CH 1211 Geneva, Switzerland
    Vaccine 23:4158-66. 2005
  9. ncbi request reprint Public health measures in the control of viral hepatitis: a World Health Organization perspective for the next millennium
    Daniel Lavanchy
    Department of Communicable Diseases Surveillance and Response, World Health Organization, Geneva, Switzerland
    J Gastroenterol Hepatol 17:S452-9. 2002
  10. doi request reprint Hepatitis B virus, hepatitis C virus and other blood-borne infections in healthcare workers: guidelines for prevention and management in industrialised countries
    D Fitzsimons
    World Health Organization, Geneva, Switzerland
    Occup Environ Med 65:446-51. 2008

Collaborators

Detail Information

Publications14

  1. doi request reprint The global burden of hepatitis C
    Daniel Lavanchy
    World Health Organization, Geneve, Switzerland
    Liver Int 29:74-81. 2009
    ..A working group was created to assist the World Health organization (WHO) in estimating the GBD associated with HCV infection...
  2. ncbi request reprint Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention
    D Lavanchy
    World Health Organization, Department of Communicable Diseases Surveillance and Response, Geneva, Switzerland
    J Clin Virol 34:S1-3. 2005
    ....
  3. ncbi request reprint Hepatitis C: public health strategies
    D Lavanchy
    World Health Organization WHO, Communicable Diseases Surveillance and Response, Geneva, Switzerland
    J Hepatol 31:146-51. 1999
    ..Wherever possible, such studies should be performed to enable countries to prioritise their preventive measures and to make the most appropriate use of available resources...
  4. ncbi request reprint Hepatitis C
    D Lavanchy
    World Health Organization, Communicable Diseases Surveillance and Response, Geneva, Switzerland
    Can J Gastroenterol 14:67B-76B. 2000
    ....
  5. ncbi request reprint Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures
    D Lavanchy
    World Health Organization, Communicable Disease Surveillance and Response, Geneva, Switzerland
    J Viral Hepat 11:97-107. 2004
    ..Promising emerging new treatments include adefovir, entecavir and peginterferon alfa-2a (40 kDa)...
  6. doi request reprint Chronic viral hepatitis as a public health issue in the world
    Daniel Lavanchy
    World Health Organization WHO, HSE EPR BDP, Geneve, Switzerland
    Best Pract Res Clin Gastroenterol 22:991-1008. 2008
    ....
  7. doi request reprint Treatment of chronic hepatitis B virus infection in resource-constrained settings: expert panel consensus
    Steven T Wiersma
    World Health Organization, FCH IVB, Geneva, Switzerland
    Liver Int 31:755-61. 2011
    ..In addition, a research agendum was developed focusing on issues related to prevention and treatment of chronic HBV in resource-constrained settings...
  8. ncbi request reprint Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants
    David FitzSimons
    World Health Organization, Via Appia 20, CH 1211 Geneva, Switzerland
    Vaccine 23:4158-66. 2005
    ..The main focus was on universal vaccination programmes with data being presented from Italy, Saudi Arabia, Singapore, Spain, Taiwan, Thailand, The Gambia, and USA (Alaska)...
  9. ncbi request reprint Public health measures in the control of viral hepatitis: a World Health Organization perspective for the next millennium
    Daniel Lavanchy
    Department of Communicable Diseases Surveillance and Response, World Health Organization, Geneva, Switzerland
    J Gastroenterol Hepatol 17:S452-9. 2002
  10. doi request reprint Hepatitis B virus, hepatitis C virus and other blood-borne infections in healthcare workers: guidelines for prevention and management in industrialised countries
    D Fitzsimons
    World Health Organization, Geneva, Switzerland
    Occup Environ Med 65:446-51. 2008
    ..Participants also identified a number of terms that need harmonization or standardisation in order to facilitate communication between experts...
  11. ncbi request reprint Prevention of hepatitis C virus infection
    M Kew
    South African Medical Research Council Cancer Association of South Africa University Molecular Hepatology Research Unit, Department of Medicine, University of the Witwatersrand, and Johannesburg Hospital, Johannesburg, South Africa
    J Viral Hepat 11:198-205. 2004
    ..Based on the presentations and discussions, a number of specific recommendations were made, which should be considered in conjunction with previously published recommendations...
  12. ncbi request reprint Planning for the next pandemic of influenza
    I D Gust
    WHO Collaborating Centre for Reference and Research on Influenza, Melbourne, Australia
    Rev Med Virol 11:59-70. 2001
    ..It has also prepared guidelines to assist national agencies in their planning. However, there may be further options for increasing our preparedness which should also be considered...
  13. pmc Decrease in the prevalence of hepatitis B and a low prevalence of hepatitis C virus infections in the general population of the Seychelles
    P Bovet
    University Institute for Social and Preventive Medicine, Lausanne, Switzerland
    Bull World Health Organ 77:923-8. 1999
    ....